Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
FENNEC PHARMACEUTICALS INC. | Director | Stock Option | 225K | $1.77M | $7.88 | Jun 3, 2025 | Direct |
Gain Therapeutics, Inc. | Director | Common Stock | 881K | $880K | $1.00 | Aug 9, 2024 | Indirect |
Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | $87.9K | $5.86 | Jun 24, 2025 | Direct |
Gain Therapeutics, Inc. | Director | Common Stock | 50K | $49.9K | $1.00 | Aug 9, 2024 | Direct |
Processa Pharmaceuticals, Inc. | Director | Common Stock | 121K | $36.3K | $0.30 | Mar 31, 2022 | by Elion Oncology, Inc. |
Processa Pharmaceuticals, Inc. | Director | Common Stock | 72.5K | $21.7K | $0.30 | Mar 31, 2022 | Direct |
Processa Pharmaceuticals, Inc. | Director | Restricted Stock | 18.2K | Jan 1, 2022 | Direct |